The effects of Omega-3 fatty acids and vitamin D supplementation on the quality of life and blood inflammation markers in newly diagnosed breast cancer women: An open-labelled randomised controlled trial

Adult; Biomarkers; Breast Neoplasms; C-Reactive Protein; Cholecalciferol; Dietary Supplements; Fatty Acids, Omega-3; Female; Humans; Inflammation; Middle Aged; Quality of Life; Tumor Necrosis Factor-alpha; Vitamin D; C reactive protein; creatinine; cyclophosphamide; docosahexaenoic acid; doxorubicin; icosapentaenoic acid; omega 3 fatty acid; tumor necrosis factor; vitamin D; biological marker; C reactive protein; colecalciferol; omega 3 fatty acid; tumor necrosis factor; vitamin D; abdominal discomfort; adult; anthropometry; appetite; Article; blood sampling; body mass; breast cancer; cancer staging; cancer therapy; constipation; controlled study; diarrhea; diet supplementation; dyspnea; enzyme linked immunosorbent assay; European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; face-to-face interview; fatigue; female; health status; histopathology; hospital personnel; human; human epidermal growth factor receptor 2 negative breast cancer; inflammation; international physical activity questionnaire short form; leukocyte count; lymph node metastasis; major clinical study; middle aged; multiple cycle treatment; nausea; physical activity; platelet count; quality of life; randomized controlled trial; sexuality; vitamin supplementation; vomiting; xerostomia; blood; breast tumor; dietary supplement; drug therapy; metabolism